CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $262K invested in Can-Fite BioPharma in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.61K
2
+$245

Top Sellers

1
-$22K
2
-$16.3K
3
-$9.5K
4
UBS Group
UBS Group
Switzerland
-$5.28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$187K
2
$20.1K
3
$18.4K
4
$16.5K
5
$7.36K
6
$5.31K
7
$3.67K
8
$3.39K
9
$327
10
$245
11
$164
12
–